In this module, we take a closer look at the role GLP-1 plays in the cardiovascular system and the therapeutic potential of GLP-1 receptor agonists (GLP-1RAs) to improve cardiovascular outcomes in people with type 2 diabetes.
By the end of this module, you will be able to:
✓ Explain the multifactorial basis for increased risk of cardiovascular disease (CVD) and reduced life expectancy in type 2 diabetes
✓ Explain the various physiological mechanisms by which GLP-1 receptor agonists might affect the course of CVD in people with type 2 diabetes and the potential role of GLP-1 receptor agonists in preventing atherosclerosis
✓ Plan how GLP-1 receptor agonists can be used in the management of type 2 diabetes to reduce the risk of CVD
This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.